Literature DB >> 28317045

Fibrolamellar variant of hepatocellular carcinoma presenting during pregnancy: management dilemmas.

Nagalapuram Vishnu1, Aditya V Kulkarni2, Sreenivasan Vidhyalakshmi3, Swaminathan Sambandam1, Prerna Garg4, Venkatakrishnan LeelaKrishnan2, Krishnaveni Janarthan2, Gursharan Singh1, Maninder Kaur5, T V Chitra6, Biku Joseph John1.   

Abstract

The Fibrolamellar variant of Hepatocellular Carcinoma (FLHCC) is a rare form of liver cancer that presents in the 3rd decade of life, is rarely associated with cirrhosis or chronic Hepatitis B/C virus infection, and usually presents with normal serum alpha-fetoprotein (AFP) levels. FLHCC presenting during pregnancy is extremely rare, with only 4 cases reported. We present a case of FLHCC in pregnancy and discuss the dilemmas in management. A 26 year-old primigravida, 26 weeks of gestation presented with a month's history of obstructive jaundice secondary. Investigations revealed a mass in the left lateral segment of the liver with extension down the left hepatic duct into the common bile duct. Following an emergency caesarean section at 31 weeks, she underwent a left hepatectomy with extrahepatic bile duct excision. The postoperative course was uneventful. Histopathology showed FLHCC. In conclusion, liver tumors presenting during pregnancy should be managed in a multidisciplinary setup with facilities for neonatal intensive care. Management depends on the presumed pathology, period of gestation and family preferences.

Entities:  

Keywords:  Fibrolamellar; Hepatocellular cancer; Liver; Pregnancy; Tumor

Year:  2017        PMID: 28317045      PMCID: PMC5353910          DOI: 10.14701/ahbps.2017.21.1.48

Source DB:  PubMed          Journal:  Ann Hepatobiliary Pancreat Surg        ISSN: 2508-5859


  4 in total

1.  Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma.

Authors:  G El-Gazzaz; W Wong; M K El-Hadary; B K Gunson; D F Mirza; A D Mayer; J A Buckels; P McMaster
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

Review 2.  Imaging features of fibrolamellar hepatocellular carcinoma.

Authors:  Dhakshinamoorthy Ganeshan; Janio Szklaruk; Vikas Kundra; Ahmed Kaseb; Asif Rashid; Khaled M Elsayes; Khaled Elsayes
Journal:  AJR Am J Roentgenol       Date:  2014-03       Impact factor: 3.959

3.  Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.

Authors:  Hashem B El-Serag; Jessica A Davila
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

4.  Outcome of patients with fibrolamellar hepatocellular carcinoma.

Authors:  Francesco Stipa; Sam S Yoon; Kui Hin Liau; Yuman Fong; William R Jarnagin; Michael D'Angelica; G Abou-Alfa; Leslie H Blumgart; Ronald P DeMatteo
Journal:  Cancer       Date:  2006-03-15       Impact factor: 6.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.